Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Fintech
  • Markets
  • News
  • Short Ideas
  • Top Stories
  • Trading Ideas

Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company

By Bhavik Nair
January 31, 10:09 PM
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: 

ARKF

Read More
3 minute read
  • ETFs
  • News
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Don’t Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023

By Chris Katje
January 23, 2:34 PM
The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.

ARKF

Read More
2 minute read
  • General
  • Health Care
  • Long Ideas
  • Top Stories
  • Trading Ideas

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest’s Flagship Fund, Catapulting Past Zoom, Tesla

By Shanthi Rexaline
January 11, 12:19 PM
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.

ARKG

Read More
2 minute read
  • Biotech
  • Broad U.S. Equity ETFs
  • ETFs
  • General
  • Markets
  • News
  • Small Cap

Cathie Wood Gets Elon Musk’s Attention Over Gene-Editing Therapy Potential: ‘Investors Chased The Dream Then. Now, They’re Running Away’

By Bhavik Nair
January 5, 12:48 AM
Cathie Wood of ARK Investment Management believes U.S. equity markets are the polar opposite of what they were in the 90s when investors chased their dreams.

ARKG

Read More
2 minute read
  • Broad U.S. Equity ETFs
  • ETFs
  • Long Ideas
  • Markets
  • News
  • Short Ideas
  • Trading Ideas

War, Inflation, Fed Hawkishness, Elon Musk’s Twitter Buy: How These Factors Weighed On Cathie Wood’s Top Holdings In 2022

By Bhavik Nair
January 2, 3:51 AM
In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks.

ARKG

Read More
3 minute read
  • ETFs
  • News
  • Specialty ETFs
  • Top Stories

‘Study The Mindset Of Stonk Hodlers’: This Fund Manager Rips Cathie Wood’s Investment Strategy

By Chris Katje
December 22, 2:55 PM
ETF fund manager Cathie Wood is known for investing in growth stocks and what she has labeled as “innovation.” A take by the fund manager drew criticism from a hedge fund manager.

ARKF

Read More
2 minute read
  • Biotech
  • Broad U.S. Equity ETFs
  • ETFs
  • General
  • Long Ideas
  • Markets
  • News
  • Short Ideas
  • Small Cap
  • Trading Ideas

Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health

By Bhavik Nair
December 7, 7:14 AM
Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based on Tuesday’s closing price.

ARKG

Read More
2 minute read
  • ETFs
  • Events
  • Federal Reserve
  • General
  • Hedge Funds
  • Large Cap
  • Markets
  • News
  • Penny Stocks
  • Sector ETFs
  • Small Cap
  • SPACE
  • Top Stories
  • Trading Ideas

Cathie Wood Increases Stake In 4 Stocks By Over 1,000% – Plus 4 New Holdings For Ark

By Robert Kuczmarski
November 22, 12:33 PM
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.

ADBE

Read More
2 minute read
  • ETFs
  • News
  • Trading Ideas

Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest’s ETFs In Canada

By Shanthi Rexaline
November 19, 3:48 PM
Cathie Wood’s Ark Invest, this week, announced a deal with Canadian investment manager BMO Capital Markets.

ARKG

Read More
2 minute read
  • Broad U.S. Equity ETFs
  • ETFs
  • Long Ideas
  • Markets
  • News
  • Small Cap
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month Over Figma Deal

By Bhavik Nair
October 10, 9:09 PM
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the

ADBE

Posts navigation

1 2 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service